Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05268562 · ClinicalTrials.gov registry record · Phase 4
Ketamine and Kidney Injury in Cardiac Surgery
A Phase 4 study of Cardiac Surgery, sponsored by Mayo Clinic.
- Active
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05268562: Active Phase 4 study of Cardiac Surgery, sponsored by Mayo Clinic.
NCT05268562 is a Phase 4 study of Cardiac Surgery that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 735-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05268562, a Phase 4 study of Cardiac Surgery, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.
Primary Outcome
The incidence of acute kidney injury in patients following cardiac surgery
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Propofol
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2026-06 |
| Phase | Phase 4 |
What the registry record for NCT05268562 still lists
NCT05268562 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 735-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.
NCT05268562 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05268562 about?
NCT05268562 is a clinical study titled "Ketamine and Kidney Injury in Cardiac Surgery". The purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.
What is the current status of trial NCT05268562?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2022-03-02. Estimated completion is 2026-06.
What conditions does trial NCT05268562 study?
This clinical trial studies the following conditions: Cardiac Surgery.
What interventions are being tested in trial NCT05268562?
The interventions under investigation include: Ketamine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT05268562?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05268562 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05268562's enrollment target sits among peer trials
200 8th of 19 higher than 12 of 19 other Cardiac Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
COMPLETED · Phase 4
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
RECRUITING · Early Phase 1
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI